David Main
Chief Executive Officer chez Notch Therapeutics, Inc.
Profil
David J.
Main was the founder of Aquinox Pharmaceuticals, Inc. founded in 2003, where he held the titles of Chairman, President & Chief Executive Officer until 2019.
He currently holds the position of President & Chief Executive Officer at Notch Therapeutics, Inc. since 2020.
Additionally, he is a Director at Discovery Parks Trust, Orum Therapeutics, Inc., and Orum Therapeutics USA, Inc. He also held the position of Vice President at QLT, Inc. from 1990 to 1996.
Mr. Main received his undergraduate degree and MBA from the University of British Columbia.
Postes actifs de David Main
| Sociétés | Poste | Début |
|---|---|---|
| Discovery Parks Trust | Director/Board Member | - |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Chief Executive Officer | 20/07/2020 |
Orum Therapeutics, Inc.
 Orum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Orum Therapeutics, Inc. operates as a biotechnology company which operates cell-penetrating antibody platform. The firm leverages its cell penetrating antibody platform to inhibit drug targets undruggable by small molecule or current antibody therapeutics. The company was founded by Seung-Ju Lee and Yong-Sung Kim on August 17, 2016 and is headquartered in Daejeon, South Korea. | Director/Board Member | 22/03/2022 |
Orum Therapeutics USA, Inc.
 Orum Therapeutics USA, Inc. BiotechnologyHealth Technology Part of Orum Therapeutics, Inc., Orum Therapeutics USA, Inc. is a biotechnology company that develops tumor-directed targeted protein degraders. The private company is based in Cambridge, MA. The company was founded in 2016 by Sung Joo Lee. Sung Joo Lee has been the CEO since 2016. | Director/Board Member | - |
Anciens postes connus de David Main
| Sociétés | Poste | Fin |
|---|---|---|
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Chief Executive Officer | 09/08/2019 |
| NEUROGENE INC. | President | 08/08/2019 |
Aquinox Pharmaceuticals (Canada), Inc.
 Aquinox Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals (Canada), Inc. manufactures pharmaceuticals for blood caner treatment. The company is headquartered in Vancouver, Canada. | Chief Executive Officer | 01/08/2019 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01/12/2016 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Chairman | 04/05/2016 |
Formation de David Main
| University of British Columbia | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Entreprise privées | 15 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
1322256 Alberta Ltd.
 1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
BC Biotech
 BC Biotech Investment Trusts/Mutual FundsMiscellaneous BC Biotech is a Canadian biotechnology company that works in the field of applied biology, using engineering, medicine, and technology in conjunction with living organisms and bioprocesses. BC Biotech also provides information on how to study biotechnology in school and which institutions are known for their program. The non-profit company is based in Vancouver, Canada. The company aims to promote businesses in the biotechnology industry and inform people about the science behind it. | Miscellaneous |
Accel-Rx
 Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Finance |
Orum Therapeutics, Inc.
Orum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Orum Therapeutics, Inc. operates as a biotechnology company which operates cell-penetrating antibody platform. The firm leverages its cell penetrating antibody platform to inhibit drug targets undruggable by small molecule or current antibody therapeutics. The company was founded by Seung-Ju Lee and Yong-Sung Kim on August 17, 2016 and is headquartered in Daejeon, South Korea. | Commercial Services |
Aquinox Pharmaceuticals (Canada), Inc.
Aquinox Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals (Canada), Inc. manufactures pharmaceuticals for blood caner treatment. The company is headquartered in Vancouver, Canada. | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Health Technology |
Orum Therapeutics USA, Inc.
Orum Therapeutics USA, Inc. BiotechnologyHealth Technology Part of Orum Therapeutics, Inc., Orum Therapeutics USA, Inc. is a biotechnology company that develops tumor-directed targeted protein degraders. The private company is based in Cambridge, MA. The company was founded in 2016 by Sung Joo Lee. Sung Joo Lee has been the CEO since 2016. | Health Technology |
| Discovery Parks Trust |
